Eligibility criteria for the GELATO trial
BONE LESIONS, DISEASE, RECURRENCE
Eligible patients had metastatic or incurable locally advanced ILC. Non-female patients were also eligible for the trial. Sex of the patients was determined based on ID check upon hospital administration. The median age of the patients in the study was 60 years, ranging from 45 to 69 years. Patients were not preselected based on PD-L1 expression. Patients had to have a metastatic lesion or recurrence available for sequential biopsies (bone lesions were not allowed) and had to have evaluable disease according to RECISTv1.1 (ref. 